Literature DB >> 6269989

Fanconi's anemia: anomaly of enzyme passage through the nuclear membrane? Anomalous intracellular distribution of topoisomerase activity in placental extracts in a case of Fanconi's anemia.

E Wunder, U Burghardt, B Lang, L Hamilton.   

Abstract

In cells of Fanconi's anemia (FA) spontaneous breakage of chromosomes was first recognized by Schroeder et al. (1964). Sensitivity to bivalent alkylants has been found to be a constant feature, whereas low levels of several repair-related enzymes have been described in different FA cell lines. In a family with known FA, during a further pregnancy the prenatal diagnosis of the disease was made by cytogenetic analysis of amniotic cells. After birth the fresh placenta was extracted for further enzymologic analysis. An unusual distribution of DNA topoisomerase activity was noted: high in the cytoplasm and only a little activity in the nuclear sap. This contrasts with findings in normal placentae. Since amniotic cells, lymphocytes, and fibroblasts of this child exhibited both high spontaneous breakage of chromosomes and sensitivity to the bivalent alkylant, diepoxybutane, a correlation between the findings on cytogenetic and enzymologic levels is assumed. Whereas in other published cases, a true reduction of activities of enzymes involved in DNA replication and repair has been found, the present results suggest the interpretation that in our patient the genetic anomaly does not affect the level of synthesis of the enzyme itself, but the passage of the enzyme from the place of synthesis (the cytoplasm) to the substrate (inside the nucleus). A genetic anomaly of the nuclear membrane might be a possible explanation, or alternatively, a structural mutation of the enzyme at a site not affecting the catalytic activity, but affecting the membrane passage or intranuclear accumulation. Meanwhile, placentae of two other cases gave similar results, thus supporting our findings.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269989     DOI: 10.1007/bf00278700

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  46 in total

1.  Is Fanconi's anaemia defective in a process essential to the repair of DNA cross links?

Authors:  M S Sasaki
Journal:  Nature       Date:  1975-10-09       Impact factor: 49.962

2.  Genetic heterogeneity in xeroderma pigmentosum: complementation groups and their relationship to DNA repair rates.

Authors:  K H Kraemer; H G Coon; R A Petinga; S F Barrett; A E Rahe; J H Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

Review 3.  Proteins that affect DNA conformation.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

5.  Nuclear transplantation and the control of gene activity in animal development.

Authors:  J B Gurdon
Journal:  Proc R Soc Lond B Biol Sci       Date:  1970-12-01

6.  Spontaneous chromosomal breakage and high incidence of leukemia in inherited disease.

Authors:  T M Schroeder; R Kurth
Journal:  Blood       Date:  1971-01       Impact factor: 22.113

7.  Carcinogen-induced chromosome breakage in Fanconi's anaemia heterozygous cells.

Authors:  A D Auerbach; S R Wolman
Journal:  Nature       Date:  1978-01-05       Impact factor: 49.962

8.  Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method.

Authors:  A D Auerbach; B Adler; R S Chaganti
Journal:  Pediatrics       Date:  1981-01       Impact factor: 7.124

9.  Assembly of SV40 chromatin in a cell-free system from Xenopus eggs.

Authors:  R A Laskey; A D Mills; N R Morris
Journal:  Cell       Date:  1977-02       Impact factor: 41.582

10.  Genetic heterogeneity of Fanconi's anemia demonstrated by somatic cell hybrids.

Authors:  S Zakrzewski; K Sperling
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

View more
  9 in total

1.  Pregnancy outcomes in mothers of offspring with inherited bone marrow failure syndromes.

Authors:  Neelam Giri; Helen D Reed; Pamela Stratton; Sharon A Savage; Blanche P Alter
Journal:  Pediatr Blood Cancer       Date:  2017-08-12       Impact factor: 3.167

2.  Complementation studies between Fanconi's anemia cells with different DNA repair characteristics.

Authors:  S Zakrzewski; M Koch; K Sperling
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

3.  Intracellular distribution of DNA topoisomerase I in fibroblasts from patients with Fanconi's anaemia.

Authors:  B Auer; H P Vosberg; U Buhre; H Klocker; M Hirsch-Kauffmann; M Schweiger
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

4.  Fanconi anemia cells have a normal gene structure for topoisomerase I.

Authors:  H Saito; M Grompe; T L Neeley; P M Jakobs; R E Moses
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

5.  Further studies on compartmentalisation of DNA-topoisomerase I in Fanconi anemia tissue.

Authors:  E Wunder
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells.

Authors:  H Youssoufian
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

7.  Proliferative kinetics and mitomycin C-induced chromosome damage in Fanconi's anemia lymphocytes.

Authors:  K Miura; K Morimoto; A Koizumi
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Cytogenetic toxicity of antitumor platinum compounds in Fanconi's anemia.

Authors:  E H Poll; F Arwert; H Joenje; A W Eriksson
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  DNA repair dependent NAD+ metabolism is impaired in cells from patients with Fanconi's anemia.

Authors:  H Klocker; B Auer; M Hirsch-Kauffmann; H Altmann; H J Burtscher; M Schweiger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.